In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) today is issuing a Health Information Advisory. This is to assure the American public that there is no known threat of contamination in infant formula manufactured by companies that have met the requirements to sell infant formula in the United States. Although no Chinese manufacturers of infant formula have fulfilled the requirements to sell infant formula in the United States, FDA officials are investigating whether or not infant formula manufactured in China is being sold in specialty markets which serve the Asian community.

The FDA is advising caregivers not to feed infant formula manufactured in China to infants. This should be replaced with an appropriate infant formula manufactured in the United States as mentioned below. Individuals should contact their health care professional if they have questions regarding their infant’s health or if they note changes in their infant’s health status.

The FDA began investigating the reports of contamination immediately and received information from the companies who manufacture infant formula for the American market that they are not importing infant formula or source materials from China. The following manufacturers have met the necessary FDA requirements for marketing milk-based infant formulas in the United States: Abbott Nutritionals, Mead Johnson Nutritionals, Nestle USA, PBM Nutritionals, and Solus Products LLC. Also, one manufacturer, SHS/Nutricia, Liverpool, England, markets an amino acid based exempt infant formula that does not contain any milk-derived ingredients.

We are asking state officials to work with the Agency to assist with the removal of any Chinese infant formula found on store shelves, and to warn members of the Asian community to avoid using Chinese manufactured infant formula.

It has been reported that a number of infants in China who have consumed Chinese manufactured infant formula are suffering from kidney stones, a condition which is rare in infants.  The Chinese manufactured infant formula may be contaminated with melamine. Melamine artificially increases the protein profile of milk and can causes kidney diseases such as those seen in these Chinese infants.

FDA requires that all infant formula manufacturers register with the Agency and adhere to specific labeling and nutritional requirements.  All properly registered infant formula manufacturers marketing infant formula in the United States undergo an annual inspection of their production facilities.

Mars Petcare US announced a voluntary recall of products manufactured at its Everson, Pennsylvania facility. The pet food is being voluntarily recalled because of potential contamination with Salmonella serotypeSchwarzengrund. This voluntary recall only affects the United States. 

Salmonella can cause serious infections in dogs and cats, and, if there is cross contamination caused by handling of the pet food, in people as well, especially children, the aged, and people with compromised immune systems.  Healthy people potentially infected with Salmonella should monitor themselves for some or all of the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping and fever. On rare occasions, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms. Consumers exhibiting these signs after having contact with this product should contact their healthcare providers.

Pets with Salmonella infections may be lethargic and have diarrhea or bloody diarrhea, fever, and vomiting. Some pets will have only decreased appetite, fever and abdominal pain.  Animals can be carriers with no visible symptoms and can potentially infect other animals or humans. If your pet has consumed the recalled product and has these symptoms, please contact your veterinarian.

The company stopped production at the Everson facility on July 29, 2008 when it was alerted of a possible link between dry pet food produced at the plant and two isolated cases of people infected with Salmonella Schwarzengrund.

Even though no direct link between product produced at Everson and human or pet illness has been made, Mars Petcare US is taking precautionary action to protect pets and their owners by announcing a voluntary recall of all products produced at the Everson facility beginning February 18, 2008 until July 29, 2008 when we stopped production.

The company is continuing to work collaboratively with the FDA to determine the nature and source of Salmonella Schwarzengrund at the Everson facility. Since it has not yet identified the source of the Salmonella Schwarzengrund at the Everson facility, Mars Petcare US does not plan to resume production out of a commitment to the safety of our pet owners and their pets, customers, and associates.

The top priority of Mars Petcare US has always been and continues to be the health and welfare of pets and their owners. Consumers can continue to have confidence in the quality and safety of the products produced at other Mars Petcare US facilities. Only those products which were produced at the Everson facility are impacted by the voluntary recall.

Many of the brands involved in the recall are national brands produced at multiple facilities. A chart for all products is below. For example, PEDIGREE® is manufactured in numerous facilities throughout the country, and Everson represents a very small portion of the manufacturing base – 2.7 percent of total PEDIGREE® production.

Mars Petcare US will work with retail customers to ensure that the recalled products are not on store shelves. These products should not be sold or fed to pets.  In the event that consumers believe they have purchased products affected by this voluntary recall, they should return the product to the store where they purchased it for a full refund.  Specific product details and other information can be found at www.petcare.mars.com